Comparison of eptifibatide and abciximab in the in-hospital outcomes and thrombocytopenia during percutaneous coronary intervention

被引：0
|
作者：
Suleiman, M [1 ]
Gruberg, L [1 ]
Halabi, M [1 ]
Nikolsky, E [1 ]
Grenadier, E [1 ]
Boulus, M [1 ]
Markiewicz, W [1 ]
Beyar, R [1 ]
机构：
[1] Rambam Med Ctr, Dept Cardiol, Haifa, Israel
来源：
EUROPEAN HEART JOURNAL | 2002年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：434 / 434
页数：1
相关论文
共 50 条
  • [1] Clinical outcomes associated with abciximab versus eptifibatide during percutaneous coronary intervention
    Ting, HH
    Lennon, RJ
    Long, KH
    McMurtry, EK
    Hammes, LN
    Wood, DL
    Holmes, DR
    Rihal, CS
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 9L - 9L
  • [2] Outcomes and costs of abciximab versus eptifibatide for percutaneous coronary intervention
    Coons, JC
    Seybert, AL
    Saul, MI
    Kirisci, L
    Kane-Gill, SL
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (10) : 1621 - 1626
  • [3] Switch from abciximab to eptifibatide during percutaneous coronary intervention
    Wahlin, Magnus
    Albertsson, Per
    Karlsson, Thomas
    Matejka, Goeran
    Odell, Annika
    Tahmasebiepour, Farshad
    Wolmeryd, Christina
    Grip, Lars
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 134 (03) : 393 - 400
  • [4] Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention
    Fahdi, IE
    Saucedo, JF
    Hennebry, T
    Ghani, M
    Sadanandan, S
    Garza-Arreola, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (04): : 453 - 455
  • [5] Impact of Chronic Thrombocytopenia on In-Hospital Outcomes After Percutaneous Coronary Intervention
    Ayoub, Karam
    Marji, Meera
    Ogunbayo, Gbolahan
    Masri, Ahmad
    Abdel-Latif, Ahmed
    Ziada, Khaled
    Vallurupalli, Srikanth
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (18) : 1862 - 1868
  • [6] Comparison of Abciximab and Eptifibatide on Angiographic and Clinical Outcomes in Rescue Percutaneous Coronary Intervention for Failed Fibrinolytic Therapy
    Bajaj, Ravi R.
    Mohammad, Atif
    Hong, Tony
    Irfan, Affan
    Sharieff, Waseem
    Bagnall, Alan
    Christie, Jo-Ann
    Kutryk, Michael J. B.
    Chisholm, Robert J.
    Cheema, Asim N.
    JOURNAL OF INVASIVE CARDIOLOGY, 2010, 22 (08): : 347 - 352
  • [7] Thrombocytopenia after abciximab use during percutaneous coronary intervention
    Gribbin, GM
    Thambyrajah, J
    Wright, RA
    Hall, JA
    Harcombe, AA
    De Belder, MA
    EUROPEAN HEART JOURNAL, 2003, 24 : 544 - 544
  • [8] In-Hospital Outcomes Following Coronary Atherectomy During Percutaneous Coronary Intervention
    Skinner, Kristina
    Paul, Timir
    Kumar, Sachin
    Hashemzadeh, Mehrtash
    Movahed, Mohamed
    Shanmugasundaram, Madhan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S16 - S17
  • [9] Comparison of Catheterization Laboratory Initiated Abciximab and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes (an ACUITY Substudy)
    Kirtane, Ajay J.
    Parise, Helen
    Mehran, Roxana
    Moses, Jeffrey W.
    Fahy, Martin
    Bertrand, Michel E.
    Ohman, E. Magnus
    White, Harvey D.
    Feit, Frederick
    Colombo, Antonio
    McLaurin, Brent T.
    Cox, David A.
    Ware, James H.
    Pocock, Stuart J.
    Lansky, Alexandra J.
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (02): : 180 - 186
  • [10] Effects of Baseline Thrombocytopenia on In-hospital Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention
    Shiraishi, Jun
    Koshi, Nariko
    Matsubara, Yuki
    Nishimura, Tetsuro
    Ito, Daisuke
    Kimura, Masayoshi
    Kishita, Eigo
    Nakagawa, Yusuke
    Hyogo, Masayuki
    Sawada, Takahisa
    INTERNAL MEDICINE, 2019, 58 (12) : 1681 - 1688
12345